Delivery Order SPE2DE24D0021-SPE2D625F1ARV
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $2,764.60 by the Defense Medical Supply Chain for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The delivery order, issued on August 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 6, 2025. The work will be performed in Pittsburgh, Pennsylvania. This award represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300.00 on August 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency, and is structured as a child contract under a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,211.68 for SOFIA 2 Flu + SARS Antigen Fluorescent reagents under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, is classified as a child contract with an ultimate completion date of September 29, 2025. The place of performance is Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's competitive...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,423.36 on July 31, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is scheduled for completion by September 26, 2025. The contract was awarded without a set-aside designation through open competition to the Medical Supply Chain, a defense-focused federal agency. As a...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2,211.68 on August 8, 2025, for the supply of Sofia 2 Flu + SARS Antigen Fluorescent diagnostic testing kits. The contract is scheduled for completion by October 6, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's competitive standing as a major supplier of laboratory and medical...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,808.52 for SOFIA SARS antigen FIA test kits (25-pack units) under a fixed-price contract with economic price adjustment provisions. The award, issued on July 21, 2025, with an ultimate completion date of September 2, 2025, will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and supports the Medical Supply Chain division of a defense-oriented federal...
- Fisher Scientific Company L.L.C. was awarded a $3,300 fixed-price delivery order by the Medical Supply Chain division of the Department of Defense on August 20, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract represents an individual delivery order issued under a larger acquisition vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of October 17, 2025. This award was made through open competition with no...
- The U.S. government's Defense agency, specifically the Medical Supply Chain, awarded a $2,750.00 fixed-price delivery order contract to Fisher Scientific Company L.L.C. (doing business as Fisher Scientific) on October 25, 2024. The contract, which does not have a set-aside designation, is for the delivery of SOFIA 2 FLU + SARS Antigen Fluorescent I test kits and is set to be completed by December 24, 2024. Fisher Scientific is a major supplier of scientific products, equipment, and services to...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F1ARVDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 14, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies with a ceiling value of $4,400. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by October 10, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's competitive standing as a major federal supplier of laboratory and medical equipment. The funding agency is the Medical Supply Chain, a defense-oriented federal entity responsible for maintaining and distributing critical medical supplies to defense operations and personnel. As a long-established vendor registered in the System for Award Management since 2001, Fisher Scientific brings extensive experience in providing specialized diagnostic and laboratory equipment to federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense. This delivery order represents a continuation of the company's role in supporting federal diagnostic and testing initiatives, with the fluorescent antigen testing supplies serving detection and diagnostic functions for respiratory pathogens. The contract's brief performance timeline and modest ceiling value indicate this is a targeted procurement to fulfill immediate supply requirements within the Medical Supply Chain's operational needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/14/25 |